SureTrader
Interactive Brokers Advertisement
Home > Boards > Canadian > Cannabis > Aphria Inc (TSX:APH)

From today's Financial Times:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
john1311 Member Profile
Member Level 
Followed By 12
Posts 1,320
Boards Moderated 1
Alias Born 10/19/15
160x600 placeholder
The Therapeutic Potential of Pharmacologically Active Cannabinoids "NetworkNewsWire" - 12/12/2017 8:45:00 AM
S&P Dow Jones Indices annonce des modifications aux indices canadiens S&P/TSX "PR Newswire (Canada)" - 12/8/2017 8:08:00 PM
S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices "PR Newswire (Canada)" - 12/8/2017 5:15:00 PM
Purified Cannabinoids Open New Opportunities in Pain Management "NetworkNewsWire" - 12/5/2017 8:45:00 AM
L'OCRCVM permet la reprise de la négociation - APH "PR Newswire (Canada)" - 12/4/2017 4:09:00 PM
IIROC Trade Resumption - APH "PR Newswire (Canada)" - 12/4/2017 4:07:00 PM
Suspension de la négociation par l'OCRCVM - APH "PR Newswire (Canada)" - 12/4/2017 4:03:00 PM
IIROC Trading Halt - APH "PR Newswire (Canada)" - 12/4/2017 4:01:00 PM
Aphria enters into supplier agreement with Shoppers Drug Mart "PR Newswire (Canada)" - 12/4/2017 3:57:00 PM
Investors Could Reap Global Rewards of Research into Medical Cannabis Science "NetworkNewsWire" - 11/30/2017 8:45:00 AM
Aphria Achieves Next Milestone in International Expansion Strategy with Receipt of Dealer's License "PR Newswire (Canada)" - 11/23/2017 8:00:00 AM
Coming Cannabis Recreational Demand in Canada Triggers Massive Investment "NetworkNewsWire" - 11/20/2017 8:45:00 AM
Biosynthesis: Making the Impossible Possible in Medicinal Cannabis "NetworkNewsWire" - 11/14/2017 8:45:00 AM
Aphria Announces Closing of Bought Deal Financing "PR Newswire (Canada)" - 11/7/2017 10:04:00 AM
Leaders in Medical Marijuana and the Global Alzheimer’s Markets "NetworkNewsWire" - 10/31/2017 8:45:00 AM
Shareholders elect Renah Persofsky and Shawn Dym to Aphria's Board of Directors "PR Newswire (Canada)" - 10/27/2017 8:00:00 AM
Biotechs Develop Proprietary Systems to Drive CBD Research and Development "NetworkNewsWire" - 10/25/2017 8:45:00 AM
Aphria Completes First Medical Cannabis Oil (CBD/THC) Shipment to Australia-based Medlab "PR Newswire (Canada)" - 10/24/2017 7:30:00 AM
Aphria engages in positive dialogue with Toronto Stock Exchange "PR Newswire (Canada)" - 10/23/2017 7:00:00 AM
Aphria welcomes new CSA disclosure guidelines, provides comment on TSX staff notice "PR Newswire (Canada)" - 10/17/2017 7:15:00 AM
Aphria reports strong performance in Q1 2018, including record revenue and grams sold "PR Newswire (Canada)" - 10/13/2017 8:00:00 AM
New Proposed Federal Tax Plan for Cannabis Underscores Need for Low Cost Producers "PR Newswire (Canada)" - 10/5/2017 8:00:00 AM
Demand Outpacing Supply as Canadian Cannabis Legalization Looms "NetworkNewsWire" - 10/3/2017 8:45:00 AM
Production Bottleneck Spells Opportunity for Canada’s Cannabis Producers "NetworkNewsWire" - 9/21/2017 8:45:00 AM
Namaste Announces Product Acquisition Agreement With Aphria Inc. "InvestorsHub NewsWire" - 9/20/2017 10:31:49 AM
john1311 Member Level  Thursday, 10/05/17 04:33:12 AM
Re: Goodbuddy4863 post# 705
Post # of 806 

From today's Financial Times:

As of Sep 29, 2017, the consensus forecast amongst 8 polled investment analysts covering Aphria Inc advises investors to purchase equity in the company. This has been the consensus forecast since the sentiment of investment analysts improved on Aug 16, 2017. The previous consensus forecast advised that Aphria Inc would outperform the market.


On Jul 12, 2017, Aphria Inc reported 4th quarter 2017 losses of -0.02 per share. This result was in line with the consensus of the 3 analysts following the company and under-performed last year's 4th quarter results by -0.04.
The next earnings announcement is expected on Oct 05, 2017.

The 10 analysts offering 12 month price targets for Aphria Inc have a median target of 8.63, with a high estimate of 13.00 and a low estimate of 6.75. The median estimate represents a 17.51% increase from the last price of 7.34.

https://markets.ft.com/data/equities/tearsheet/forecasts?s=APH:TOR




Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist